High Court Refuses Bid To Hear Prilosec Patent Spat
The U.S. Supreme Court on Monday declined to intervene in a long-running patent dispute between Swedish-U.K. drug manufacturer AstraZeneca AB and Impax Laboratories involving the gastrointestinal treatment drug Prilosec OTC....To view the full article, register now.
Already a subscriber? Click here to view full article